Cover Image
Market Research Report
Product code

Global Biopsy Devices Market, Size, Share, Opportunities and Forecast, 2020-2027

Published: | DataM Intelligence | 180 Pages | Delivery time: 2 business days


Back to Top
Global Biopsy Devices Market, Size, Share, Opportunities and Forecast, 2020-2027
Published: April 3, 2021
DataM Intelligence
Content info: 180 Pages
Delivery time: 2 business days
  • ALL
  • Description
  • Table of Contents

Global Biopsy Devices Market is segmented By Body Part (Breast Biopsy Devices, Colorectal Biopsy Devices, Lung Biopsy Devices, Liver Biopsy Devices, others), By Application (Gynecology, Urology, Interventional Cardiology, Interventional Oncology, Other Applications), By Biopsy Type (Stereotactic, Stereotactic, Needle Based, MRI Based, X-Ray Based, others), By End User (Hospital, Research Centres, Cancer Hospitals), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020-2027

Market Overview

The Global Biopsy Devices Market is expected to grow at a CAGR of 5.90% during the forecasting period (2020-2027).

The increasing frequency of various types of cancers across the globe, Rising need for early diagnosis of various diseases like cancer to avoid the death of the patient, Modernization of healthcare infrastructure etc are driving the growth of Biopsy Devices Market.

However, Risks involved in the diagnosis process, lack of skilled and trained professionals is likely to slow down the growth of the market.

In addition, increasing government initiatives to prevent the spread of cancer, adoption to modernized healthcare infrastructure is also favoring growth.

Market Segmentation

The Global Biopsy Devices market is segmented by Body Part, Application, Biopsy type, and End User.

By Body Part, the market is divided into Breast Biopsy Devices, Colorectal Biopsy Devices, Lung Biopsy Devices, Liver Biopsy Devices, Lymph node biopsy Devices, and Other Devices.

Breast Biopsy Devices is a major segment of the market. Breast Cancer stands as first place in types of cancers found in women.

WHO stats reveal that Breast cancer survival rates range from 40% in low-income countries to around 80% in North America.

The difference is mainly due to the availability of healthcare diagnostic equipment that diagnoses cancer at early stages thereby preventing the death of the patient. All these instances create a scope for the growth of the Biopsy Devices market.

By Application, the market is classified as Gynaecology, Urology, Interventional Cardiology, Interventional Radiology, Interventional Oncology, and Other Applications.

By Biopsy Type, the market is segmented as Stereotactic, Ultrasound-Guided, Needle-Based, MRI Based, X-Ray Based, and Others.

Hospitals, Research Centres, and Cancer Hospitals are the end users.

Scope of the Report

By Body Part

Breast Biopsy Devices

Colorectal Biopsy Devices

Lung Biopsy Devices

Liver Biopsy Devices

Lymph node biopsy Devices

Other Devices

By Application



Interventional Cardiology

Interventional Radiology

Interventional Oncology

Other Applications

By Biopsy Type



Needle Based

MRI Based

X-Ray Based


By End User


Research Centres

Cancer Hospitals


By Region

Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)

Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)

North America (The USA, Canada, Mexico)

South America (Brazil, Argentina, Rest of South America)

Rest of the World

The report covers factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles.

The report profiles companies like Bard Biopsy Systems, Cook Medical, Argon Medical Devices, Biopsybell, Creganna Medical, Olympus, Medtronic, Fujifilm, Hologic, and INRAD.

Geographical Analysis

This report segments the geographies by region which include North America, South America, Europe, Asia Pacific, and RoW.

North America occupies the highest share in the market followed by Europe and Asia-Pacific. The increasing number of cancer cases (an estimated number of 1,688,780 new cases of cancer in the US alone) is majorly driving the market in this region.

Europe is considered a fast-growing region in the Biopsy Devices Market, particularly in the breast biopsy devices segment. The relatively high incidence of breast cancer i.e., 89.7 per 100,000 women in this region is majorly driving the demand.

Apart from this, the Existence of key market players, growing use of various latest cancer diagnostic devices is pushing forth the demand in this region.

Why purchase the report?

Visualize the composition of the Biopsy Devices market across each indication, in terms of type and applications, highlighting the key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of the Biopsy Devices market level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for key Biopsy Devices products of all major market players.

Target Audience

Raw Material & Equipment Suppliers/ Buyers

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies


Related Reports:

Electrocardiograph (ECG) Market

Ultrasound Devices Market

Table of Contents

Table of Contents

Table of Contents

1.  Biopsy Devices Market- Methodology and Scope

  • 1.1 Research methodology
  • 1.2 Scope of the Report

2. Biopsy Devices Market - Industry Trends

  • 2.1 Key Trends & Developments

3. Biopsy Devices Market - Market Outlook

  • 3.1 Industry Impact Factors (Drivers & Restraints)
  • 3.2 Competitive Intensity- Porter 5 Forces
  • 3.3 Regulatory Analysis

4. Market Segmentation Analysis

  • 4.1. Biopsy Devices Market-By Body Part
    • 4.1.1 Breast Biopsy Devices
    • 4.1.2 Colorectal Biopsy Devices
    • 4.1.3 Lung Biopsy Devices
    • 4.1.4 Liver Biopsy Devices
    • 4.1.5 Lymph node biopsy Devices
    • 4.1.6 Other Devices
  • 4.2. Biopsy Devices Market- By Application
    • 4.2.1 Gynecology
    • 4.2.2 Urology
    • 4.2.3 Interventional Cardiology
    • 4.2.4 Interventional Radiology
    • 4.2.5 Interventional Oncology
    • 4.2.6 Other Applications
  • 4.3 Biopsy Devices Market- By Biopsy Type
    • 4.3.1 Stereotactic
    • 4.3.2 Ultrasound-Guided
    • 4.3.3 Needle Based
    • 4.3.4 MRI Based
    • 4.3.5 X-Ray Based
    • 4.3.6 Others
  • 4.4 Biopsy Devices Market- By End User
    • 4.4.1 Hospitals
    • 4.4.2 Research Centres
    • 4.4.3 Cancer Hospitals
    • 4.4.4 Others

5. Regional, Country-level Analysis

  • 5.1. North America
    • 5.1.1. The USA
    • 5.1.2. Canada
    • 5.1.3. Mexico
  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. The UK
    • 5.2.4. Italy
    • 5.2.5. Spain
    • 5.2.6. Rest of Europe
  • 5.3. Asia Pacific
    • 5.3.1. China
    • 5.3.2. Japan
    • 5.3.3. India
    • 5.3.4. Australia
    • 5.3.5. Rest of Asia Pacific
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
    • 5.4.3. Rest of South America
  • 5.5 RoW

6. Competitive Analysis

  • 6.1. Market Share Analysis
  • 6.2. Key Strategies

7.Company Profiles

  • 7.1 Bard Biopsy Systems
  • 7.2 Cook Medical
  • 7.3 Argon Medical Devices
  • 7.4 Biopsybell
  • 7.5 Creganna Medical
  • 7.6 Olympus
  • 7.7 Medtronic
  • 7.8 Fujifilm
  • 7.9 Hologic
  • 7.10 INRAD

8. Appendix

  • 8.1 Sources
  • 8.2 List of Tables
  • 8.3 Expert Panel Validation
  • 8.4 Disclaimer
  • 8.5 Contact Us